Royalty Pharma plc RPRX
$53.70▼ -0.76% 24H
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Royalty Pharma plc is the world's largest buyer of biopharmaceutical royalties and a leading funder of innovation in the life sciences sector. The company acquires royalties entitling it to payments based on net sales of approved therapies and development-stage product candidates, partnering with innovators from academ…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees100
TickerRPRX
Statistics
Market Cap$23.82B
Revenue (TTM)$2.38B
Net Income$770.9M
Net Margin32.4%
EPS$1.78
P/E28.69
P/S12.86
P/B3.51
EV/EBITDA22.08
ROE13.8%
Dividend Yield1.71%
Price$53.70
Data: Twelve Data · Revenue = mcap / P/S